» Articles » PMID: 16574086

B Cells As Antigen Presenting Cells

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2006 Apr 1
PMID 16574086
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Several characteristics confer on B cells the ability to present antigen efficiently: (1) they can find T cells in secondary lymphoid organs shortly after antigen entrance, (2) BCR-mediated endocytosis allows them to concentrate small amounts of specific antigen, and (3) BCR signaling and HLA-DO expression direct their antigen processing machinery to favor presentation of antigens internalized through the BCR. When presenting antigen in a resting state, B cells can induce T cell tolerance. On the other hand, activation by antigen and T cell help converts them into APC capable of promoting immune responses. Presentation of self antigens by B cells is important in the development of autoimmune diseases, while presentation of tumor antigens is being used in vaccine strategies to generate immunity. Thus, detailed understanding of the antigen presenting function of B cells can lead to their use for the generation or inhibition of immune responses.

Citing Articles

Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.

De Domenico P, Gagliardi F, Roncelli F, Snider S, Mortini P J Neurooncol. 2025; .

PMID: 40080248 DOI: 10.1007/s11060-025-04989-z.


The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.

Zhou Y, Wu Y, Zhao X, Xu L, Sun M, Meng Z Front Immunol. 2025; 16:1515730.

PMID: 39917308 PMC: 11798770. DOI: 10.3389/fimmu.2025.1515730.


Pan-cancer analysis of B3GNT5 with potential implications for cancer immunotherapy and cancer stem cell stemness.

Peng F, Feng Y, Yu S, He R, Wang H, Xie Y PLoS One. 2024; 19(12):e0314609.

PMID: 39671359 PMC: 11642946. DOI: 10.1371/journal.pone.0314609.


Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses.

Zhu D, Du Y, Zhao M, Ablikim D, Huang H, Pan W Hepatol Int. 2024; 19(1):93-105.

PMID: 39630171 DOI: 10.1007/s12072-024-10753-8.


Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation.

Chauhan S, Dunn C, Andresen N, Rossevold A, Skorstad G, Sike A NPJ Breast Cancer. 2024; 10(1):30.

PMID: 38653982 PMC: 11039627. DOI: 10.1038/s41523-024-00638-2.